AI in Drug Development Faces Data Challenges

Quick Summary

• Artificial intelligence (AI) has significant potential for drug revelation but remains in its early developmental stages.
• Effective advancement of AI in this field requires large, open, non-proprietary, and high-quality datasets for training and validation.

Indian Opinion Analysis
AI-driven drug discovery represents an chance for transformative advancements in healthcare globally, including India. While AI technology is still maturing in this domain,IndiaS strong pharmaceutical industry and growing expertise in AI offer a chance to become a leader if collaborative frameworks are established to share data responsibly and securely. Encouraging partnerships between academia and private players to create open datasets can accelerate innovation while ensuring ethical standards remain intact.Read More